highperformr logo

Arvinas's Overview

Total employees439
HeadquartersNew Haven
Founded2013

Arvinas is a clinical-stage biopharmaceutical company at the forefront of developing a new class of medicines based on targeted protein degradation. Utilizing its proprietary PROTAC® (PROteolysis TArgeting Chimera) platform technology, Arvinas aims to harness the body's natural protein disposal system to selectively and efficiently remove disease-causing proteins. The company's primary focus is on creating novel treatments for cancers and other debilitating diseases with high unmet medical needs. Arvinas is advancing a pipeline of product candidates in multiple therapeutic areas, including oncology and neuroscience.

Where is Arvinas's Headquarters?

HQ Function

The New Haven headquarters serves as the central hub for Arvinas's research and development, clinical operations, and corporate functions.

Notable Features:

State-of-the-art laboratory facilities, collaborative workspaces designed to foster innovation, located within the Science Park at Yale, a vibrant bioscience cluster.

Work Culture:

Arvinas fosters a dynamic and innovative work environment. The culture is rooted in scientific rigor, collaboration across diverse teams, and a shared mission to impact patient lives. The atmosphere is intellectually stimulating, encouraging cutting-edge research in protein degradation.

HQ Significance:

The headquarters' location provides access to a rich talent pool, academic collaborations (including proximity to Yale University), and a supportive biotech ecosystem, crucial for Arvinas's pioneering research and development efforts.

Values Reflected in HQ: The facility's design and location emphasize innovation, scientific excellence, and collaboration, directly supporting Arvinas's core values and mission to develop novel medicines for patients.

Location:

While Arvinas's primary R&D and corporate operations are centered in the U.S. (New Haven, CT), the company maintains a global reach through its clinical trials conducted across North America, Europe, and Asia-Pacific. It also operates a research center in Suzhou, China, to support its discovery efforts. Furthermore, Arvinas engages in strategic collaborations with global pharmaceutical partners to advance its pipeline and technology platform.

Street Address:

5 Science Park

City:

New Haven

State/Province:

CT

Country:

USA

Arvinas's Global Presence

Suzhou, Jiangsu, China

Address: Arvinas Protein Degradation Research Center Co., Ltd., Building C17, 218 Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu, China

To tap into the growing scientific talent and research capabilities in China, expand global research footprint, and accelerate the discovery phase of novel protein degraders.

Buying Intent Signals for Arvinas

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Arvinas

As of April 2025, Arvinas' leadership includes:

John Houston, Ph.D. - President and Chief Executive Officer
Ian Taylor, Ph.D. - Chief Scientific Officer
Sean Cassidy - Chief Financial Officer
Randy TeWinkel - Chief Commercial Officer
Angela Cacace, Ph.D. - Chief Business Officer
Paul McInerney, J.D. - Chief Legal Officer
Lisa Sinclair - Chief People Officer
Ashley Winslow, Ph.D. - Chief Development Officer

Investors of Arvinas

Arvinas has been backed by several prominent investors over the years, including:

The Vanguard Group
BlackRock Inc.
RA Capital Management
FMR LLC (Fidelity)
EcoR1 Capital, LLC
RTW Investments, LP
State Street Corporation
Wellington Management Group LLP

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits0

Arvinas has strategically strengthened its leadership team over the past 12 months with key appointments in legal and commercial functions, aligning with its progression as a clinical-stage company preparing for potential product launches. No major executive departures were publicly highlighted during this period.

New Appointments:

Paul McInerney, J.D., Paul McInerney appointed as Chief Legal Officer.
Randy TeWinkel, Randy TeWinkel appointed as Chief Commercial Officer.

Technology (Tech Stack) used by Arvinas

Discover the tools Arvinas uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Arvinas Email Formats and Examples

Arvinas commonly uses the 'first.last' email format. Variations might exist, but this is the most frequently observed pattern for company communications.

firstname.lastname@arvinas.com

Format

john.doe@arvinas.com

Example

85%

Success rate

News and media

Arvinas, Inc.May 9, 2024

Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Updates

Arvinas announced its financial results for the first quarter of 2024 and provided updates on its pipeline programs, including progress on its PROTAC® protein degraders vepdegestrant (ARV-471) and ARV-766....more

Arvinas, Inc.May 7, 2024

Arvinas Announces Presentations on Vepdegestrant (ARV-471) at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

Arvinas highlighted multiple presentations featuring new data and analyses for its novel estrogen receptor PROTAC® degrader, vepdegestrant, at the ESMO Breast Cancer 2024....more

Arvinas, Inc.April 8, 2024

Arvinas to Present Preclinical Data on Novel KRAS G12C PROTAC® Degrader Program at the American Association for Cancer Research (AACR) Annual Meeting 2024

Arvinas announced plans to present preclinical data for its innovative KRAS G12C PROTAC® protein degrader program, showcasing its potential in targeting this challenging oncogene....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Arvinas, are just a search away.